Table 1.
The effects of bile acids on inflammatory mediators in cholestatic liver injury depends upon cell type
| Cell type | Bile acid species | Response | Mediator/pathway | References |
|---|---|---|---|---|
| Mouse hepatocytes | TCA, DCA. CDCA, Bile | Induction of inflammatory cytokines | MAPKs/Egr1 | 10, 11 |
|
| ||||
| Mouse and human hepatocytes | Major endogenous bile acids | Induction of inflammatory cytokines, neutrophil chemotaxis | ER stress, Mitochondrial damage, Tlr9 activation. | 18 |
|
| ||||
| Mouse cholangiocytes | BDL model | Secretion and cleavage of osteopontin for immune cell recruitment Cell proliferation | Excessive pressure in the biliary system/MMPs TGR5/cSrc-EGFR-MEK-ERK1/2 | 48, 54, 61 |
| TLCA, TCA | Activation of COX-2 | S1PR2/ERK1/2/NF-kB | ||
|
| ||||
| Mouse and human neutrophils | BDL model | Activation, chemotaxis and cytotoxicity | DAMPs CXC/CCL chemokines Adhesion molecules Cytoskeletal proteins | 16–18, 72–74, 80, 82 |
|
| ||||
| Mouse and human monocytes/macrophages | BDL model TC, TCDC, GCDC, TLCA, CDCA | Production of pro-or/and anti-inflammatory cytokines | TGR5/NF-kB/JNK/Inflammasome | 50, 56, 87–92, 103 |
|
| ||||
| Mouse TH cells | BDL model | Production of pro- inflammatory and fibrotic cytokine IL-17 | 93, 97 | |
|
| ||||
| Mouse NK and invariant NK T cells | BDL model | Stimulation of anti- or suppression of pro- inflammatory cytokines produced in Kupffer cells | 98, 99 | |